Literature DB >> 35982344

Duct-like diverticulum at the base of third ventricle tumors: a morphological signature diagnostic of papillary craniopharyngioma.

José María Pascual1, Ruth Prieto2, Rodrigo Carrasco3, Laura Barrios4.   

Abstract

This study describes and characterizes a narrow, hollow tubular structure, termed as duct-like diverticulum (DV), found specifically at the basal midline of papillary craniopharyngiomas (PCPs) located within the third ventricle (3V). The presence of this structure was systematically investigated on autopsy studies and magnetic resonance imaging (MRI) scans of 3536 craniopharyngioma (CP) cases published in the medical literature from 1911 to 2021, as well as in other twelve 3V tumor categories (n = 1470 cases). A basal DV was observed in a total of 50 PCPs, including two of our own cases. This DV corresponds to a tubular-shaped recess invaginated at the midline bottom of the tumor, following the same angled trajectory as the pituitary stalk. It can be easily seen as a hypointense linear structure on T1- and T2-weighted MRI scans, with two main length types: long DVs (74%), which reach the tumor center, and short DVs (26%), which penetrate the tumor only a few millimeters. The DV sign identifies the papillary CP type with a specificity of 100% and a sensitivity of 33% in the overall CP population. This finding also serves to establish the strictly intra-3V location of the lesion with a 95% specificity and 42% sensitivity among papillary CPs. No similar basal DV was found in adamantinomatous CPs nor among other categories of strictly 3V tumors. Consequently, the presence of a diverticulum in a 3V tumor represents a morphological signature pathognomonic of the papillary type and a valuable sign to reliably define the strictly 3V topography.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Craniopharyngioma; Diverticulum; Hypothalamus; Papillary craniopharyngioma; Pituitary Infundibulum; Third ventricle tumors

Mesh:

Year:  2022        PMID: 35982344     DOI: 10.1007/s10143-022-01848-7

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   2.800


  50 in total

1.  Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis.

Authors:  José María Pascual; Ruth Prieto; Rodrigo Carrasco; Laura Barrios
Journal:  J Neurosurg       Date:  2013-03-29       Impact factor: 5.115

2.  Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors.

Authors:  Ruth Prieto; José María Pascual; Maria Rosdolsky; Inés Castro-Dufourny; Rodrigo Carrasco; Sewan Strauss; Laura Barrios
Journal:  Neurosurg Focus       Date:  2016-12       Impact factor: 4.047

Review 3.  Craniopharyngioma treatment: an updated summary of important clinicopathological concepts.

Authors:  Ruth Prieto; Maria Rosdolsky; Verena Hofecker; Laura Barrios; José M Pascual
Journal:  Expert Rev Endocrinol Metab       Date:  2020-07

4.  Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.

Authors:  Tareq A Juratli; Pamela S Jones; Nancy Wang; Megha Subramanian; Simon J B Aylwin; Yazmin Odia; Elham Rostami; Olafur Gudjonsson; Brian L Shaw; Daniel P Cahill; Evanthia Galanis; Fred G Barker; Sandro Santagata; Priscilla K Brastianos
Journal:  Cancer       Date:  2019-07-17       Impact factor: 6.860

5.  A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.

Authors:  Shingo Fujio; Tareq A Juratli; Kazunori Arita; Hirofumi Hirano; Yushi Nagano; Tomoko Takajo; Koji Yoshimoto; Ivanna V Bihun; Alexander B Kaplan; Naema Nayyar; Alexandria L Fink; Mia S Bertalan; Shilpa S Tummala; William T Curry; Pamela S Jones; Maria Martinez-Lage; Daniel P Cahill; Fred G Barker; Priscilla K Brastianos
Journal:  Neurosurgery       Date:  2019-08-01       Impact factor: 4.654

6.  Papillary craniopharyngioma: a clinicopathological study of 48 cases.

Authors:  T B Crotty; B W Scheithauer; W F Young; D H Davis; E G Shaw; G M Miller; P C Burger
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

7.  Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.

Authors:  Priscilla K Brastianos; Amaro Taylor-Weiner; Peter E Manley; Robert T Jones; Dora Dias-Santagata; Aaron R Thorner; Michael S Lawrence; Fausto J Rodriguez; Lindsay A Bernardo; Laura Schubert; Ashwini Sunkavalli; Nick Shillingford; Monica L Calicchio; Hart G W Lidov; Hala Taha; Maria Martinez-Lage; Mariarita Santi; Phillip B Storm; John Y K Lee; James N Palmer; Nithin D Adappa; R Michael Scott; Ian F Dunn; Edward R Laws; Chip Stewart; Keith L Ligon; Mai P Hoang; Paul Van Hummelen; William C Hahn; David N Louis; Adam C Resnick; Mark W Kieran; Gad Getz; Sandro Santagata
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 38.330

8.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

9.  Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features.

Authors:  Qi Yue; Yang Yu; Zhifeng Shi; Yongfei Wang; Wei Zhu; Zunguo Du; Zhenwei Yao; Liang Chen; Ying Mao
Journal:  J Neurosurg       Date:  2017-10-06       Impact factor: 5.115

Review 10.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Pieter Wesseling; Daniel J Brat; Ian A Cree; Dominique Figarella-Branger; Cynthia Hawkins; H K Ng; Stefan M Pfister; Guido Reifenberger; Riccardo Soffietti; Andreas von Deimling; David W Ellison
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.